Title: Removing Barriers to Biomarker Testing Through Collaboration
- Time: Tuesday, June 28 at 9:00 a.m. Pacific Time
- Speakers: Omar Perez, Ph.D., Head of Medical Diagnostics, US Medical Affairs Oncology, AstraZeneca; Kat Kwiatkowski, Ph.D. senior vice president of clinical development, Strata Oncology; Jenn HigginsVice President, Public Affairs, Guarding Health; Nikki Martin, Director, Precision Medicine Initiatives, LUNGevity Foundation; Laura J. van’t Veer, Ph.D., Professor of Laboratory Medicine, University of California San Francisco
Title: Immuno-oncology biomarkers to predict drug efficacy
- Time: Tuesday, June 28 at 11:30 a.m. PT
- Speakers: Ronnie Andrews, President and CEO, OncoCyte; Kat Kwiatkowski, Ph.D. senior vice president of clinical development, Strata Oncology; Paul BillingsMD, Ph.D., FACP, FACMGG, CEO and Director, Biological Dynamics
Panel recordings will be available later. For more information, visit https://www.pmwcintl.com.
About the World Conference on Precision Medicine
Since 2009, the Precision Medicine World Conference (PMWC) has served as a global forum for information, innovation and inspiration for those dedicated to turning the promise of precision medicine into a reality of care. standard in the clinic. In partnership with world-class medical luminaries, StanfordUCSF, dukeUPMC and the University of Michigan, PWMC brought together representatives from industry, medicine, healthcare and government to show what is possible, examine the challenges that remain and provide an enabling environment for collaboration . See previous speakers: https://www.pmwcintl.com/previous-speakers/
About Strata Oncology
Strata Oncology, Inc. is a precision oncology company dedicated to providing the best possible treatment for every cancer patient. The company combines molecular profiling, real-world data and a large-scale clinical trial platform to identify and deliver optimal treatments for cancer patients. For more information, visit strataoncology.com.
SOURCE Strata Oncology, Inc.